TGFBR3, a receptor for TGF‐β, is implicated in various cancers, including breast cancer, melanoma, prostate cancer, pancreatic cancer, colon cancer, multiple myeloma, neuroblastoma, ovarian cancer, endometrial cancer, and lung cancer.34, 35, 36, 37, 38. The gene discussed is TGFBR3; the disease is breast carcinoma.